Does anyone here know when the Australian authorities will decide upon granting reimbursement or not? Is there a deadline? What I don’t get is that they have such a renowned Chinese professor in board, but still don’t have any trials or any partnership in place in China... Great pipeline, great study results, partnerships in Europe and in the U.S. (DepuySynthes) but that Chinese professor needs starting using his influence to get things done in China.
Does anyone here know when the Australian authorities will...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $79.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 37.0¢ | $18.95K | 50.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 60031 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 11292 | 2 |
View Market Depth
| Last trade - 15.57pm 04/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |